Beam Therapeutics Inc is trading 6.63% up at $30.95 as the market opens, tracking a broad risk-on rally across major indices.
- Major benchmarks including the S&P 500, Nasdaq, and Dow are trading sharply higher, providing a significant tailwind for growth-oriented stocks.
- Falling oil prices and improved geopolitical sentiment are further bolstering investor confidence and supporting the sector's advance.
- The move appears to be driven by macroeconomic factors, as no company-specific headlines were reported to account for the price action.